Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T cell abnormalities in systemic lupus erythematosus.

Tsutomu Takeuchi1, Kensei Tsuzaka, Thoru Abe

  • 1tsutake@saitama-med.ac.jp

Autoimmunity
|October 18, 2005
PubMed
Summary

Systemic lupus erythematosus (SLE) T cells show defective signaling due to low expression of the TCR zeta chain. Unique aberrant transcripts of this chain are found specifically in SLE patients, unlike other diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

T peripheral helper 1 cells effectively drive atypical double-negative CD11c<sup>hi</sup> B cells to antibody-secreting cells and play a pathogenic role in systemic lupus erythematosus.

Clinical immunology (Orlando, Fla.)·2026
Same author

Achievement of intermediate treatment targets for Still's disease under tocilizumab treatment: a post-hoc analysis of the phase III trial.

Immunological medicine·2026
Same author

Real-world effectiveness, safety and patient-reported outcomes of sarilumab in patients with rheumatoid arthritis: a 52-week, prospective, open-label, non-interventional, observational, nationwide, large-cohort study in Japan (PROFILE-J).

RMD open·2026
Same author

The guide for the diagnosis and treatment of connective tissue disease-associated interstitial lung disease 2025.

Respiratory investigation·2026
Same author

Immune Complexes Shape the Pathogenicity of Autoantibodies in Systemic Autoimmune Diseases: Insights From an FcγRIIIA-Reporter Assay.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Integrating B Cell Differentiation Model With Real-World Data Informs Determinants for Antibody-Secreting Cell Depletions in Systemic Sclerosis.

CPT: pharmacometrics & systems pharmacology·2026

Area of Science:

  • Immunology
  • Molecular Biology
  • Autoimmune Diseases

Background:

  • T cells are central to systemic lupus erythematosus (SLE) pathogenesis.
  • Understanding T cell dysfunction in SLE is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the molecular basis of defective T cell function in SLE patients.
  • To identify specific molecular defects in T cells from SLE individuals.

Main Methods:

  • Extensive testing of peripheral blood T cells from SLE patients.
  • Analysis of surface structures (adhesion molecules) and signal transduction molecules.
  • Comprehensive analysis of T cell receptor (TCR) zeta chain expression and transcripts.

Main Results:

Related Experiment Videos

  • Upregulated adhesion molecules and defective proximal signal transduction in active SLE T cells.
  • Attenuated or absent TCR zeta chain expression in over half of SLE patients.
  • Detection of aberrant TCR zeta chain transcripts (e.g., lacking exon 7) unique to SLE.

Conclusions:

  • Sustained attenuation and aberrant transcripts of the TCR zeta chain are unique molecular defects in SLE T cells.
  • These findings highlight specific molecular targets for SLE therapeutic strategies.
  • The unique TCR zeta defects in SLE warrant further investigation for disease-specific treatments.